-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Meeting News
-
Highlights From the 2019 IASLC Latin American Conference in Lung Cancer
By Luis E. Raez, MD, FACP, FCCP Posted: December 11, 2019 The 8th IASLC Latin American Conference in Lung Cancer (LALCA) was held in Mexico City, Mexico, from October 18 to 20, 2019. The LALCA is the main event of the IASLC Latin American Group (LATAM), which has close to 500 members in almost 20…
-
IASLC 2019 World Conference on Lung Cancer: Collaborative Formats, Novel Data
Posted: August 14, 2019 Dr. Ramon Rami-Porta The world’s largest international gathering of clinicians, researchers, and scientists in the field of lung cancer and thoracic oncology—the IASLC 2019 World Conference on Lung Cancer (WCLC)—will kick off on September 7, in Barcelona, Spain. As in previous years, more than 7,000 delegates representing more than 100 countries are…
-
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient Care
Posted: November 15, 2019 As a rare orphan disease, mesothelioma research has been slowed by a lack of eligible patients for trials and by a dearth of resources. Because of these hurdles, agreement among oncologists and researchers in the field regarding strategic priorities is necessary. The IASLC 2018 Mesothelioma Meeting held this past July in…
-
2019 IASLC World Conference on Lung Cancer Updates
Posted: November 12, 2019 More than 7,700 delegates from around the world attended the IASLC 2019 World Conference on Lung Cancer (WCLC). With sessions and workshops on every aspect of thoracic oncology patient care, the conference offered attendees from all specialties an opportunity to learn about novel research and hear from the field’s top experts.…
-
Lung Cancer Research Highlights from the 2019 ASCO Annual Meeting
By Kara Nyberg, PhD Posted: August 14, 2019 The 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) featured hundreds of lung cancer abstracts encompassing the full spectrum of this malignancy. This article highlights some of the most important NSCLC and SCLC research presented at ASCO that will help shape future areas of inquiry…
-
First School of Nursing to Be Held at 2019 Latin American Conference on Lung Cancer
By Enza Esposito Nguyen, DNP, RN, ANP-BC, AOCNP Posted: August 14, 2019 Dr. Enza Esposito Nguyen The upcoming ninth Latin American Conference on Lung Cancer—to be held in Mexico City, Mexico, in October 2019, and sponsored by the IASLC Latin American Group (LATAM)—will feature, for the first time, a notable, overdue addition: the first School of…
-
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
Posted: May 27, 2019 Mesothelioma is a rare tumor with limited treatment options. The upcoming IASLC 2019 Mesothelioma Meeting (July 10-12) in New York City—a first of its kind for this disease site—promises to provide the latest clinical trial and emerging therapy information in the field. Preclinical and early clinical trial data will be presented for…
-
IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions, Attendance
By Paul A. Bunn, Jr., MD, FASCO Posted: May 27, 2019 The 19th annual IASLC Targeted Therapies of Lung Cancer Meeting was held in Santa Monica, California, from February 20 to 23, 2019. The meeting chairs, Roy S. Herbst MD, PhD; Leora Horn, MD, MSc; Suresh S. Ramalingam, MD; and I created a program to be…
-
IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent Major Advances
By Charles M. Rudin, MD, PhD Posted: March 1, 2019 2019 IASLC Small Cell Lung Cancer Meeting April 3-5 • New York, New York Memorial Sloan Kettering Cancer Center The 2019 IASLC Small Cell Lung Cancer (SCLC) Meeting will be held at Memorial Sloan Kettering Cancer Center in New York, New York, April 3 to…
-
Scientific Highlights from the IASLC Latin America Conference on Lung Cancer
By Edgardo S. Santos Castillero, MD, FACP Posted: December 2018 Five abstracts were presented at the Presidential Symposium of the 2018 IASLC Latin America Conference on Lung Cancer, held in August in Córdoba, Argentina. All of the presentations centered on immunotherapy, with the following themes: (1) defining best treatment options as first-line therapy, (2) novel…